Eli Lilly and Company

11/12/2026 | Press release | Distributed by Public on 11/12/2026 14:41

Lilly breaks ground in Pennsylvania's Lehigh Valley on a $3.5 billion site to make next-generation obesity medicines, the latest of 10 new U.S. sites since 2020

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Eli Lilly and Company published this content on November 12, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 12, 2026 at 20:41 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]